Owner Integrative Gene Therapeutics The Regents of The University of California

Inventors Schaffer, David V.; Kaspar, Brian; Maheshri, Narendra

Agent FB Rice

Pub. Number AU-B-2004256444

PCT Pub. Number WO2005/005610

Priority 60/484,111 30.06.03 US

Filing date 29 June 2004

Wipo publication date 20 January 2005

Acceptance publication date 7 July 2011

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/015 (2006.01) Peptides having more than 20 amino acids

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

C12N 7/01 (2006.01) Viruses, e.g. bacteriophages - Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material

C12N 7/02 (2006.01) Viruses, e.g. bacteriophages - Recovery or purification

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 15/70 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for E. coli

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

C12N 15/864 (2006.01) Mutation or genetic engineering - Parvoviral vectors

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12Q 1/70 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage